Alendronate Has an Anabolic Effect on Bone Through the Differentiation of Mesenchymal Stem Cells
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We committed MSCs to differentiate into either osteoblasts or adipocytes and examined the effect of ALN on both adipogenesis and osteoblastogenesis. ALN inhibited adipogenesis while promoting osteoblast differentiation and activity. Our results reveal a new anabolic effect of ALN in differentiating bone marrow cells. Introduction: Alendronate (ALN) prevents bone loss in postmenopausal patients through the regulation of osteoclastic activity. However, it has also proven to be effective in older adults where the pathophysiological mechanism is the predominance of adipogenesis over osteoblastogenesis. The aim of this study is to determine the in vitro effect of ALN on both osteoblastogenesis and adipogenesis. Materials and Methods: Human mesenchymal stem cells (MSCs) were plated at a density of 5 × 105 cells/well in 100-cm 2 dishes containing MSC growth media. After confluence, cells were committed to differentiate adding either adipogenic or osteogenic media with and without 1,25(OH)2D3 (10−8 M) and supplemented with ALN at increasing concentrations (10−9 to 10−7 M). Untreated differentiating MSCs were used as control. Alkaline phosphatase (ALP), oil red O, and Alizarin red staining were performed at timed intervals (weeks 1 and 2). Additionally, levels of expression of both osteogenesis and adipogenesis transcription factors were measured in protein extracts. Finally, the effect of ALN on PPARγ2 nuclear activation complex was assessed. Results: We found that ALN has a significant and dose-dependent effect on osteoblastogenesis. This effect was not modified by the presence of 1,25(OH)2D3 in the medium. Furthermore, adipogenic differentiation of MSCs was affected by addition of both ALN and 1,25(OH)2D3 to the media as confirmed by phenotype changes and lower number of lipid droplets. Finally, expression of adipogenic transcription factors and PPARγ2 activation were reduced in adipose differentiating MSCs treated with either ALN or ALN + 1,25(OH)2D3. Conclusions: This study shows a potential anabolic effect of ALN in vitro through the stimulation of osteogenic differentiation of MSCs. Additionally, a previously unknown inhibitory effect of ALN on bone marrow adipogenesis was also found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779 · cited 1×
“additional to the increased bone resorption seen in postmenopausal osteoporosis,((4,5)) which is mostly caused by greater osteoclastic activity, an age-related shift in bone”
BackgroundPrevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 1×
“Finally, this effect is not limited to osteoblastogenesis but also through the promotion of osteoblast survival as per their efficacy as antiapoptotic agents in glucocorticoid-induced osteoporosis.((37))”
BackgroundBalena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., & Frankenfield, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116872 · Cited by 396
Cited by
Aging and bone loss: new insights for the clinician
Demontiero, O., Vidal, C., & Duque, G. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x11430858 · Cited by 559
Self-citationAli, D., Tencerova, M., Figeac, F., Kassem, M., & Jafari, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.981487 · Cited by 122
Physiology of the aging bone and mechanisms of action of bisphosphonates
Dominguez, L. J., Di Bella, G., Belvedere, M., & Barbagallo, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9344-5 · Cited by 66
“Interestingly, alendronate has been shown to promote osteoblastogenesis while inhibiting adipogenesis in vitro in human MSC ( Duque and Rivas 2007 ).”
BackgroundSadie-Van Gijsen, H., Hough, F. S., & Ferris, W. F. (2013) · Bone · doi:10.1016/j.bone.2013.06.016 · Cited by 48
Bisphosphonate-incorporated coatings for orthopedic implants functionalization
Zhang, J., Bai, H., Bai, M., Wang, X., Li, Z., Xue, H., Wang, J., Cui, Y., Wang, H., Wang, Y., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100737 · Cited by 22
“The above characteristics enable BPs to interact with relevant cellular sites of action, especially OCs, but also osteocytes, OBs, and BMSCs.”
BackgroundInfluential
Metadata
- Authors
- Duque, G., & Rivas, D.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 22
- Issue
- 10
- Pages
- 1603-1611
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2071426740
- Cited by
- 156
- References
- 3
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alendronate Has an Anabolic Effect on Bone Through the Differentiation of Mesenchymal Stem Cells. https://app.cochat.ai/papers/10.1359/jbmr.070701
- The paper
- Duque, G., & Rivas, D. (2007). Alendronate Has an Anabolic Effect on Bone Through the Differentiation of Mesenchymal Stem Cells. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.070701
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.